|
Arno Therapeutics Reports Third Quarter 2014 Financial and Business Update
GlobeNewswire (press release) For the nine months ended September 30, 2014, Arno reported net income of $3.2 million, or $0.16 per share, which includes non-cash income of $20.8 million for the decrease in derivative liability of common stock warrants, and $3.5 million of non-cash … |
